Podcasts about Ophthalmic

To mark the 100th anniversary of Ophthalmic and Physiological Optics (OPO), four past editors — Neil Charman, Bernard Gilmartin, Christine Dickinson, and David Elliott — along with the current editor, Mark Rosenfield, sat down for a special podcast to reflect on their experiences as editors.OPO is the research journal of The College of Optometrists. It is read and cited around the world, and helps clinicians and educators stay up to date with the latest research findings on the development, use and restoration of vision.In Part 2, the editors talk about what they would have done differently during their time in the role and offer insights into the current state of research and OPO.Further information⁠OPO - The College research journal

To mark the 100th anniversary of Ophthalmic and Physiological Optics (OPO), four past editors — Neil Charman, Bernard Gilmartin, Christine Dickinson, and David Elliott — along with the current editor, Mark Rosenfield, sat down for a special podcast to reflect on their experiences as editors.OPO is the research journal of The College of Optometrists. It is read and cited around the world, and helps clinicians and educators stay up to date with the latest research findings on the development, use and restoration of vision.In Part 1, each former editor discusses their time in the role, including how they left their mark on the publication and the challenges they faced.Further informationOPO - The College research journal

Send us a textIn this episode of the Life Science Success Podcast my guest is Thomas Ruggia, the President and CEO of Samsara Vision, a specialty medical device company focused on developing innovative implantable ophthalmic technologies to improve vision for individuals with untreatable retinal disorders. With extensive experience in ophthalmology from his previous roles at Johnson & Johnson and Alcon, Thomas brings a wealth of knowledge and passion to Samsara Vision's mission of rejuvenating eyesight and helping people reconnect with the world around them.00:00 Introduction to Life Science Success Podcast00:34 Meet Thomas Ruggia: CEO of Samsara Vision01:38 Thomas Ruggia's Journey into the Medical Device Industry03:14 Career Highlights: Alcon and Johnson & Johnson11:49 Samsara Vision's Flagship Product: Seeing IMT17:31 Future of Ophthalmic Devices and Treatments27:26 Personal Insights and Leadership Advice31:08 Global Perspective and Concerns34:46 Excitement for Future Technologies40:19 Conclusion and Farewell

Neuro-ophthalmic deficits significantly impair quality of life by limiting participation in employment, educational, and recreational activities. Low-vision occupational therapy can improve cognition and mental health by helping patients adjust to visual disturbances. In this episode, Katie Grouse, MD, FAAN, speaks with Sachin Kedar, MD, FAAN, author of the article “Symptomatic Treatment of Neuro-ophthalmic Visual Disturbances” in the Continuum® April 2025 Neuro-ophthalmology issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Kedar is the Cyrus H Stoner professor of ophthalmology and a professor of neurology at Emory University School of Medicine in Atlanta, Georgia. Additional Resources Read the article: Symptomatic Treatment of Neuro-ophthalmic Visual Disturbances Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @AIIMS1992 Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Sachin Kedar about his article on symptomatic treatment of neuro-ophthalmic visual disturbances, which appears in the April 2025 Continuum issue on neuro-ophthalmology. Welcome to the podcast, and please introduce yourself to our audience. Dr Kedar: Thank you, Katie. This is Sachin Kedar. I'm a neuro-ophthalmologist at Emory University, and I've been doing this for more than fifteen years now. I trained in both neurology and ophthalmology, with a fellowship in neuro-ophthalmology in between. It's a pleasure to be here. Dr Grouse: Well, we are so happy to have you, and I'm just so excited to be discussing this article with you, which I found to be a real treasure trove of useful clinical information on a topic that many find isn't covered enough in their neurologic training. I strongly recommend all of our listeners who work with patients with visual disturbances to check this out. I wanted to start by asking you what you hope will be the main takeaway from this article for our listeners? Dr Kedar: The most important takeaway from this article is, just keep vision on your radar when you are evaluating your patients with neurological disorders. Have a list of a few symptoms, do a basic screening vision, and ask patients about how their vision is impacting the quality of life. Things like activities of daily living, hobbies, whether they can cook, dress, ambulate, drive, read, interact with others. It is very important for us to do so because vision can be impacted by a lot of neurological diseases. Dr Grouse: What in the article do you think would come as the biggest surprise to our listeners? Dr Kedar: The fact that impairment of vision can magnify and amplify neurological deficits in a lot of what we think of as core neurological disorders should come as a surprise to most of the audience. Dr Grouse: On that note, I think it's probably helpful if you could remind us about the types of visual disturbances we should be thinking about and screening for in our patients? Dr Kedar: Patients who have neurological diseases can have a whole host of visual deficits. The simplest ones are deficits of central vision. They can have problems with their visual field. They can have abnormalities of color vision or even contrast sensitivity. A lot of our patients also complain of light sensitivity, eyes feeling tired when they're doing their usual stuff. Some of our patients can have double vision, they can have shaky vision, which leads to their sense of imbalance and maybe a fall risk to them. Dr Grouse: It's really helpful to think about all the different aspects in which vision can be affected, not just sort of the classic loss of vision. Now, your article also serves as a really important reminder, which you alluded to earlier, about how impactful visual disturbances can be on daily activities. Could you elaborate a little further on this, and particularly the various domains that can be affected when there are visual disturbances present? Dr Kedar: So, when I look at how visual disturbances affect quality of life, I look at two broad categories. One is activities of basic daily living. These would be things like, are you able to cook? Are you able to ambulate not just in your home, but in your neighborhood? Are you able to drive to your doctor's appointment or to visit with your family? Are you able to dress yourself appropriately? Are you able to visualize the clothing and choose them appropriately? And then the second category is recreational activities. Are you able to read? Are you able to watch television? Are you able to visit the theatre? Are you able to travel? Are you able to participate in group activities, be it with your family or be it with your social group? It is very important for us to ask our patients if they have problems doing any of this because it really can adversely impact the quality of life. Dr Grouse: I think, certainly with all the things we try to get through talking with our patients, this may not be something that we do spend a lot of time on. So, I think it's it is a good reminder that when we can, being able to ask about these are going to be really important and help us hit on a lot of other things we may not even realize or know to ask about. Now, I was really struck when I was reading your article by the meta-analysis that you had quoted that had showed 47% higher risk of developing dementia among the visually impaired compared to those without visual impairments. Should we be doing more in-depth visual testing on all of our patients with cognitive symptoms? Dr Kedar: This is actually the most interesting part of this article, and kind of hones in on the importance of vision in neurological disorders. Now I want to clarify that patients with visual disorders, it's not a causative influence on dementia, but if you have a patient with an underlying cognitive disorder, any kind of visual disturbance will significantly make it worse. And this has been shown in several studies, both in the neurologic and in the ophthalmological literature. So, I quoted one of the big meta-analysis over there, but studies have clearly shown that if you have these patients and treat them for their visual deficits, their cognitive indices can actually significantly improve. To answer your question, I would say a neurologist should include basic vision screening as part of every single evaluation. Now, I know it's a hard thing in, you know, these days when we are literally running on the hamster wheel, but I can assure you that it won't take you more than 2 to 3 minutes of your time to do this basic screening; in fact, you can have one of your assistants included as part of the vital signs assessment. What are these basic screening tools? Measure the visual acuity for both near and distance. Check and see if their visual field's off with the confrontation. Look at their eye movements. Are they able to move their eyes in all directions? Are the eyes stable when they're trying to fixate on a particular point? I think if you can do these basic things, you will have achieved quite a bit. Dr Grouse: That's really helpful, and thanks for going through some of the standard, or really, you know, solid basic foundation of visual testing we should be thinking about doing. I wanted to move on to some more details about the visual disturbances. You made an excellent point that there are many types of primary ophthalmologic conditions that can cause visual disturbances that we should keep in mind. So maybe not things that we think about a lot on a day-to-day basis, but, you know, are still there and very common. What are some of the most common ones, and when should we be referring them to see an ophthalmologist? Dr Kedar: So, it depends on the age group of your patient population. Now, the majority of us are adult neurologists, and so the kinds of ophthalmic conditions that we see in this population is going to be different from the pediatric age group. So in the adult population, we might see patients with uncorrected refractive error, presbyopia, patients who have cataracts creep on them, they may have glaucoma, they may have macular degeneration, and these tend to have a slightly higher incidence in the older age group. Now for those of us who are taking care of the younger population, uncorrected refractive errors, strabismus and amblyopia tend to be fairly common causes of visual deprivation in this age group. What I would encourage all of our neurologists is, make sure that your patients get a basic eye examination at least once a year. Just like you want them to go to their primary care and get an annual maintenance visit, everybody should go to the ophthalmologist or the optometrist and get a basic examination. And, if you're resourceful enough, have your patients bring a copy of that assessment. Whether it is normal or there's some abnormality, it is going to help you in the management. Dr Grouse: Absolutely. I think that's a great piece of advice, to think of it almost, like, them seeing their primary care doctor, which of course we offer encourage our patients to do, thinking of this as another very important piece of standard primary care. If a patient comes to you reporting difficulty reading due to possible visual disturbances, I'm curious, can you walk us through how you would approach this evaluation? Dr Kedar: It is not a very common presenting complaint of our patients, even in the neuro-ophthalmology clinic. It's a very rare patient that I see who comes and says, I cannot read or, I have difficulty reading. Most of the patients will come saying, oh, I cannot see. And then you have to dig in to find out, what does that actually mean? What can you not see? Is it a problem in your driving? Is it a problem in your reading? Or is it a problem that occurs at all times? Now you asked me, how do you approach this evaluation? One of the things that all of us, whether we are neurologists, ophthalmologists, or neuro-ophthalmologists, forget to do is to actually have the patient read a paragraph, a sentence, when they are in clinic. And that will give you a lot of ideas about what might actually be going wrong with the patient. Now, as far as how do I approach this evaluation, I will do a basic screening examination to make sure that their visual acuity is good for both distance and near. A lot of us tend to do either distance or near and we will miss the other parameter. You want to do a basic confrontation visual field to make sure that they do not have any subtle deficits that's impacting their ability to read. Examine the eye movements, do a fundoscopic examination. Now, once you've done this basic screening, as a neurologist, you already have some idea of whether your patient has a lesion along the visual pathways. If you suspect that this is a problem with, say, the visual pathways, ask your ophthalmology colleague to do a formal visual field assessment, and that'll pick up subtle deficits of central visual field. And lastly, don't forget higher visual function testing or cortical visual function testing. So basically, you're looking for neglect, phenomenon, or simultanagnosia, all of which tends to have an impact on reading. So, in the manuscript I have a schema of how you can approach a patient with reading difficulties, and in that ischemia you will see categories of where things can go wrong during the process of reading. And if you can approach your patient systematically through one of those domains, there's a fairly good chance that you'll be able to pick up a problem. Dr Grouse: Going a little further on to when you do identify problems with loss of central or peripheral vision, what are some strategies for symptomatic management of these types of visual disturbances? Dr Kedar: As a neurologist, if you pick up a problem with the vision, you have to send this patient to an eye care provider. The vast majority of people who have visual disturbances, it's from an eye disease. You know, as I alluded to earlier, it can be something as simple as uncorrected refractive error, and that can be fixed easily. A lot of patients in our older age group will have dry eye syndrome, which means they are unable to adequately lubricate the surface of the eye, and as a result, it degrades the quality of their vision. So, they tend to get intermittent episodes of blurred vision, or they tend to get glare. They tend to get various forms of optical aberration. Patients can have cataracts, patients can have glaucoma or macular degeneration. And in all of those instances, the goal is to treat the underlying disease, optimize the vision, and then see what the residual deficit is. By and large, if a patient has a problem with the central vision, then magnification will help them for activities that they perform at near; say, reading. Now for patients with peripheral vision problem, it's a different entity altogether. Again, once you've identified what the underlying cause is, your first goal is to treat it. So, for example, if your patient has glaucoma, which is affecting peripheral vision, you're going to treat glaucoma to make sure that the visual field does not progress. Now a lot of what happens after that is rehabilitation, and that is always geared towards the specific activities that are affected. Is it reading? Is it ambulating? Is it watching television? Is it driving? And then you can advise as a neurologist, you can advise your occupational therapist or low vision specialist and say, hey, my patient is not able to do this particular activity. Can we help them? Dr Grouse: Moving on from that, I wanted to also hit on your approach when patients have disorders of ocular motility. What are some things you can do for symptomatic management of that? Dr Kedar: So, patients with ocular motility can have two separate symptoms. Two, you know, two disabling symptoms, as they would call it. One is double vision and the other is oscillopsia, or the feeling or the visualization of the environment moving in response to your eyes not being able to stay still. Typically, you would see this in nystagmus. Now, let's start with diplopia. Diplopia is a fairly common presenting complaint for neurologists, ophthalmologists, and the neuro-ophthalmologist. The first aspect in the management of diplopia is to differentiate between monocular diplopia and binocular diplopia. Now, monocular diplopia is when the double vision persists even after covering one eye. And that is never a neurological issue. It's almost always an ophthalmic problem, which means the patient will then have to be assessed by an eye care provider to identify what's causing it. And again, refractive error, cataracts, opacities, they can do it. Now, if the patient is able to see single vision by covering one eye at a time, that's binocular diplopia. Now, in patients with binocular diplopia in the very early stages of the disease, the standard treatment regimen is just monocular occlusion. Cover one eye, the diplopia goes away, and then give it time to improve on its own. So, this is what we would typically do in a patient with, say, acute sixth nerve palsy or fourth nerve palsy or third nerve palsy, maybe expect spontaneous improvement in a few months. Now if the double vision does not improve and persists long term, then the neuro-ophthalmologist or the ophthalmologist will monitor the amount of deviation to see if it fluctuates or if it stays the same. So, what are the treatment options that we have in a patient who absolutely refuses any intervention or is not a candidate for any intervention? Monocular occlusion still remains the viable option. Now, patients who have stable ocular deviation can benefit from using prisms in their glasses, or they can be sent to a surgeon to have a strabismus surgery that can realign their eyes. So, again, a broad answer, but there are options available that we can use. Dr Grouse: Thank you for that overview. I think that's just really helpful to keep in mind as we're working with these patients and thinking about what their options are. And then finally, I wanted to touch on patients with higher-order vision processing and attention difficulties. What are some strategies for them? Dr Kedar: These are frankly the most difficult patients that I get to manage in my clinic, simply because there is no effective therapies for managing them. In fact, I think neurologists are far better at this than ophthalmologists or even neuro-ophthalmologists. In patients with attentional disorders, everything boils down to the underlying cause, whether you can treat it or whether it is a slowly progressive, you know, condition, such as from neurodegenerative diseases. And that tailors our goals towards therapy. The primary goal is for safety. A lot of these patients who have visual disturbances from vision processing or attention, they are at accident and fall risk. They have problems with social interactions. And, importantly, there is a gap of understanding of what's going on, not just from their side but also from the family's side. So, I tend to approach these patients from a safety perspective and social interaction perspective. Now, I have a table listed in the manuscript which will go into details of what the specific things are. But in a nutshell, if your patient has neglect in a specific part of the visual field, they have accident risk on that side. Simple things like walking through a doorway, they can hurt their shoulders or their knees when they bang into the wall on that side because they are unable to judge what's on the other side. Another example would be a patient who has simultanagnosia or a downgaze policy, such as from progressive super nuclear policy. They are unable to look down fast enough, or they are simply unable to look down and appreciate things that are on the floor, and so they can trip and fall. Walking downstairs is also not a huge risk because they are unable to judge distances as they walk down. A lot of what we see in these patients are things that we have to advise occupational therapists and help them improve these safety parameters at home. Another thing that we often forget is patients can inadvertently cause a social incident when they tend to ignore people on their affected side. So, if there is a family gathering, they tend to consistently ignore a group of people who are sitting on the affected side as opposed to the other side. And I've had more than a few patients who've come and said that, I may have offended some of my friends and family. In those instances, it's always helpful when they are in clinic to demonstrate to the family how this can be awkward and how this can be mitigated. So, having everybody sit on one side is a useful strategy. Advise your family and friends before a gathering that, hey, this may happen. And it is not because it is deliberate, but it's because of the medical condition. And that goes a lot, you know, further in helping our patients come out of social isolation because they are also afraid of offending people, you know. And they can also participate socially, and it can overall improve their quality of life. Dr Grouse: That's a really helpful tip, and something I'll keep in mind with my patients with neglect and visual field cuts. Thank you so much for coming to talk with us today. Your article has been so helpful, and I urge everybody listening today to take a look. Dr Kedar: Thank you, Katie. It was wonderful talking to you. Dr Grouse: I've been interviewing Dr Sachin Kedar about his article on symptomatic treatment of neuro-ophthalmic visual disturbances, which appears in the most recent issue of Continuum on neuro-ophthalmology. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

In this episode of The Rob & Jai Show, Dr. Rob Rothman and Dr. Jai Parekh host a captivating conversation with Andrew Stewart and Anthony Wallace—two leaders who are among the most experienced and admired executives in ophthalmology. Andrew Stewart, with over 25 years of pharmaceutical leadership across Bausch + Lomb, AbbVie, and Allergan, shares how his global business acumen shapes innovation in eye care. Anthony Wallace, a 26-year healthcare veteran with leadership roles at Novartis, Merck, and GlaxoSmithKline, reflects on leading Bausch + Lomb's U.S. Surgical business and his passion for patient-centered solutions. Both leaders bring a wealth of knowledge, relatable stories, and a shared commitment to advancing ophthalmic care.In this episode, you'll learn:

We all rely on artificial intelligence in our daily lives. From Siri to Google Maps and Netflix recommendations, AI is a constant presence. But did you know it is also transforming eye care and ophthalmology? From advanced diagnostics to research and personalized treatments, ophthalmic artificial intelligence (AI) is shaping the future of vision care.

Dr Benjamin Burt is an ophthalmic surgeon with specialist training in cosmetic eyelid surgery, an ophthalmic surgeon for over 15 years. Benjamin specializes in ophthalmic surgery of the orbit eyelids, the periorbital area, face and thereconstruction of the eye and associated structures.His specialty is to perform meticulous Upper and Lower blepharoplasties and forehead lifts for men and women.Benjamin's based in Melbourne, Australia, where he isrecognised as 'the surgeon you want if you need your eyes done'! He spoke with Hanya Oversby last week about his incredible work in both the medical and aesthetic spheres.For more information on Dr Benjamin, please click on this linkhttps://drbenjaminburt.com.au/ More information about Hanya Oversby can be found onhttps://hanyaoversby.com.au/

Interview with Bradley J. Katz, MD, PhD, author of Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide. Hosted by Neil Bressler, MD. Related Content: Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide

Interview with Bradley J. Katz, MD, PhD, author of Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide. Hosted by Neil Bressler, MD. Related Content: Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide

Dr. Davin Ashraf is an Assistant Professor of Ophthalmology at the Casey Eye Institute (Oregon Health and Science University) in the division of Oculofacial Plastic Surgery. He acts as host in this episode of the Oculofacial Podcast. Dr. Robert Kersten is a Professor and ASOPRS Fellowship Program Director at the Moran Eye Center (University of Utah) within the division of Oculoplastic and Facial Plastic Surgery. Dr. Shravani Mikkilineni is an oculofacial surgeon in private practice at Consultants in Ophthalmic and Facial Plastic Surgery in the metro Detroit area. Dr. Emily Li is an Assistant Professor at the Wilmer Eye Institute (Johns Hopkins University). Episode Summary: Dive into the November-December 2024 issue of Oculofacial Plastic and Reconstructive Surgery (OPRS) as Dr. Davin Ashraf leads engaging discussions with expert colleagues Dr. Robert Kersten, Dr. Shravani Mikkilineni, and Dr. Emily Li. The episode covers cutting-edge topics and insightful research findings in oculoplastic surgery, providing listeners with an in-depth understanding of the latest surgical techniques and postoperative outcomes in the specialty. Dr. Robert Kersten initiates the podcast with an exploration of the phenylephrine test's influence on the outcomes of external levator advancement surgery. Key discussions revolve around the phenylephrine's role in selecting the appropriate approach to ptosis surgery and its implication for eyelid compliance. Following this, Dr. Shravani Mikkilineni highlights significant corneal astigmatism changes post-levator surgery, sparking considerations for toric intraocular lens surgery timing. Dr. Emily Li concludes the episode by presenting an innovative surgical technique to address punctal stenosis, prompting dialogue on traditional methods' efficacy. Together, these discussions offer a comprehensive look into evolving methodologies and patient management strategies in oculoplastic surgery. Key Takeaways: Phenylephrine Test Utilization: Dr. Kersten discusses how phenylephrine positive patients had better outcomes in external levator resection and challenges common practices involving phenylephrine tests. Corneal Astigmatism Considerations: Changes in corneal astigmatism post-levator surgery could impact future toric IOL procedures, emphasizing the need for careful preoperative evaluation. Novel Approach to Punctoplasty: The podcast explores traditional versus novel techniques in handling punctal stenosis, weighing practicality against surgical outcomes. Resources: Casey Eye Institute, Oregon Health and Science University Moran Eye Center, University of Utah Wilmer Eye Institute, Johns Hopkins University Consultants in Ophthalmic and Facial Plastic Surgery Explore this enlightening episode to gain valuable insights and stay informed about critical topics in the field of oculoplastic surgery. Be sure to tune in for future episodes filled with expert discussions and cutting-edge discoveries in ophthalmology.  

In this episode of The Rob and Jai Show from OIS XIV, hosts Dr. Rob Rothman and Dr. Jai Parekh talk with Eric Schlumpf, CEO of Stuart Therapeutics, about the company's transformative approach to ophthalmic diseases. Learn how Stuart's innovative polypeptide technology repairs damaged collagen, advancing from dry eye to neuroprotection in glaucoma and beyond. Eric highlights key milestones, including promising clinical trial results, strategic partnerships, and the company's plans to tackle major unmet needs like myopia and inherited retinal diseases.In this episode, you'll learn:How Stuart Therapeutics' polypeptide platform is revolutionizing ophthalmic treatments.The potential for neuroprotection in glaucoma and what makes Stuart's approach unique.Why Stuart's dry eye clinical program could be a market differentiator.The exciting data supporting new indications like myopia and inherited retinal disease.How strategic partnerships are fueling innovation in a capital-efficient way.Tune in for an engaging conversation on the cutting edge of ophthalmic innovation, and find out why Stuart Therapeutics is one of the hottest companies to watch in ophthalmology.

Host Dr. Amanda Redfern welcomes Dr. Sravanthi Vegunta, a pediatric and neuro-ophthalmologist, to explain how to select the right radiologic imaging when you suspect a neuro-ophthalmic disorder. Dr. Vegunta breaks down idiopathic intracranial hypertension (IIH), papilledema, optic neuritis, optic atrophy, third and fourth cranial nerve palsies, Horner syndrome, and nystagmus.  For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Ophthalmologists are not spared from the opioid epidemic. Recent studies have shown that opioids continue to be prescribed after ophthalmic surgeries. Dr. Drew Carey interviews Dr. Matthew R. Starr on his retrospective study published in Ophthalmology, “Hospitalization, Overdose, and Mortality After Opioid Prescriptions Tied to Ophthalmic Surgery.” Hospitalization, Overdose, and Mortality After Opioid Prescriptions Tied to Ophthalmic Surgery. Thao, Viengneesee et al. Ophthalmology, Volume 131, Issue 8, 943 – 949. Join Ophthalmology's Editor-in-Chief, Russell Van Gelder, as he presents “The Year in Literature: Editor's Choice Highlights From the Ophthalmology Journal Family”  in Chicago at AAO 2024 on Sunday October 20, 2024, at 2pm local time in McCormick Place South Building Room S406A. Search “SYM48” in the Mobile Meeting Guide for more information.

On this episode, I was joined by Maysaa Attar, Senior Vice President of R&D at Bausch + Lomb. On this episode, Maysaa discusses: 00:00 Welcome to Episode 150! 03:00 Challenges and Innovations in Ocular Drug Delivery 09:30 Understanding Intravitreal Injections 13:26 Regulatory Considerations for Ocular Products 20:48 Innovations in Glaucoma Treatment 29:18 The Personal Impact of Vision Loss 35:40 Book Recommendations and Final Thoughts Maysaa Attar is the Senior Vice President of R&D at Bausch & Lomb, leading global pharmaceutical and consumer product research and development. She has held prominent leadership positions at Abbvie and Allergan and holds a PhD in Pharmaceutical Sciences from the University of Southern California (USC), where she also serves as a professor.

Host Dr. Jay Sridhar welcomes Dr. Gareth Lema to discuss his group's recent study published in Ophthalmology that quantified the amount of eye drop waste in ophthalmic clinics and the implications for practice. When handled appropriately, argues Dr. Lema, eye drops can be used until the FDA-regulated expiration date, and thus help reduce both their carbon footprint and costs while still providing safe and effective patient care. Read more: Tan JM, Chen B, Vail D et al. Ophthalmic drop waste due to self-imposed use cessation dates. Ophthalmology. 2024, Jul 1:S0161-6420(24)00391-9. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Brand new technology that customises your eye surgery. Our expert today was Dr Arthur Cummings Consultant Ophthalmic Surgeon and Medical Director at the Wellington Eye Clinic.

Arthur Cummings, Consultant Ophthalmic Surgeon at the Wellington Eye Clinic is our expert this morning on the show.

This podcast summarises the article 'Comparison of veterinarians and a deep learning tool in the diagnosis of equine ophthalmic diseases' by Annabel Scharre et al. 

Episode 108 The Bad Batch Report S3 Ep8-9 Welcome, fellow Star Wars enthusiasts, to Episode 108 of Radio Free Endor Join Jamie and Chris as they embark on another thrilling journey through the galaxy far, far away. In today's episode, we're diving headfirst into the latest Star Wars news, featuring exciting news of what to expect with new merchandise on May the 4th #StarWarsDay. But that's not all! We're also delving into our review of two action-packed episodes from Season 3 of The Bad Batch: "Bad Territory" and "The Harbinger." Also the sad passing of Samantha Davis, wife of Warwick Davies Join us as we dissect every thrilling moment, explore character developments, and share our thoughts on the latest adventures of Clone Force 99. Don't miss out on the fun—tune in now and immerse yourself in the Star Wars universe with us! #RadioFreeEndor #Episode108 #StarWarsEnthusiasts #BadBatch #BadTerritory #TheHarbinger #StarWarsDay #SamanthaDavis #JoinUs 00:00 Radio Free Endor Intro 01:38 Hellos and Welcomes 03:25 Star Wars May the 4th News ·         Star Wars May the 4th Lego ·         New Action Figures ·         Star Wars Toys ·         Star Wars day at the National Space Center ·         Samantha Davies passes away aged 53 45:08 The Bad Batch Report Season 3 ·         Episodes 8 “Bad Territory” ·         Episode 9 “The Harbinger”. 89:10 End of the Show If you want to have a say about anything Star Wars or the podcast then drop us an email or record a voicemail on your phone or pc, it can be as long as you want send them to us at radiofreeendor@gmail.com   if you would like to support the show the please head over to my Patreon page. https://www.patreon.com/sirjedijamie Radio Free Endor on YouTube Brand New Tee shirts available at Tee Publichttp://shrsl.com/?icde @radiofreeendor radiofreeendor@gmail.com @Jamie_R_burns sirjedijamie@gmail.com @ghostheadsuk ghostheadsuk@gmail.com Christopher Burns @BurnedChris @FSJamOrg https://littlepeopleuk.org/about-us Little People UK was co-founded in January 2012 by actor Warwick Davis, his wife Samantha and a group of individuals with the same goal; to offer friendship and support to people with dwarfism, their families and friends, and helping build a positive future for those individuals. Since its inception, Little People UK has become a registered charity and an essential resource for the social, medical and financier needs of the little people community in the UK. To date is attracted almost 200 members, along with the support highly respected Orthopaedic, Ophthalmic, Neurological and Anaesthetic consultant surgeons. Along with Physiotherapists and Educational practitioners, all of whom have a special interest in helping people with dwarfism. 

In this compelling OIS podcast episode, host Dr. Rob Rothman engages in an insightful conversation with Dr. Malvina Eydelman, the Director of the FDA's Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices. Delve into Malvina's unique career journey and discover how her diverse background in engineering and ophthalmology has influenced her work at the FDA. Here's what you can expect from this episode:Malvina's Journey: Learn how Malvina went from growing up in Georgia to becoming a key leader at the FDA, thanks to her strong engineering and medical background.FDA's Role in Innovation: Discover how the FDA is evolving to support innovation, with a focus on collaborative workshops and clear standards for ophthalmic devices.Leadership During COVID-19: Hear about Malvina's critical role during the COVID-19 pandemic, managing the rapid approval and production of ventilators and respiratory devices.Tips for Early Engagement with the FDA: Get valuable advice on how to navigate the FDA's processes and why early communication is crucial for success in medical device development.This episode is a must-listen for anyone interested in the intersection of healthcare, technology, and regulatory processes. Click the link to listen now!

My guest on the show today is Francois Roberge, President and CEO of LSL Pharma Group (TSX-V: LSL). LSL Pharma Group is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and distribution of high-quality natural health products and dietary supplements in solid dosage forms, as well as high quality sterile ophthalmic pharmaceutical products, according to the company's website. I invited on Francois to discuss: Developing their own pharmaceutical products in-house vs. partnering Why there is an opportunity to consolidate the fragmented CDMO (contract development and manufacturing organization) market for niche products LSL's natural health and Ophthalmic products; and, Francois' 3-5 year vision for the company For more information about LSL Pharma Group, please visit: https://www.groupelslpharma.com/ This podcast was recorded and is being made available by SNN, Inc. (together with its affiliates and its and their employees, “SNN”) solely for informational purposes. SNN is not providing or undertaking to provide any financial, economic, legal, accounting, tax, or other advice in or by virtue of this podcast. The information, statements, comments, views, and opinions provided in this podcast are general in nature, and such information, statements, comments, views, and opinions, and the viewing of/listening to this podcast are not intended to be and should not be construed as the provision of investment advice by SNN. The information, statements, comments, views, and opinions expressed in this podcast do not constitute and should not be construed as an offer to buy or sell any securities or to make or consider any investment or other course of action. The information, statements, comments, views, and opinions expressed in this podcast (including by guest speakers who are not officers, employees, or agents of SNN) are not necessarily those of SNN and may not be current. Reference to any specific third-party entity, product, service, materials, or content does not constitute an endorsement or recommendation by the SNN. SNN assumes no responsibility or liability for the accuracy or completeness of the content contained in third party materials or on third party sites referenced in this podcast or the compliance with applicable laws of such materials and/or links referenced herein. The views expressed by guest speakers are their own and their appearance on this podcast does not imply an endorsement of them or any entity they represent. SNN does not make any representation or warranty as to the accuracy or completeness of any of the information, statements, comments, views, or opinions contained in this podcast, which may include forward-looking statements where actual results may differ materially. SNN does not undertake any obligation whatsoever to provide any form of update, amendment, change, or correction to any of the information, statements, comments, views or opinions set forth in this podcast. SNN EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR OTHER DAMAGES ARISING OUT OF ANY INDIVIDUAL'S USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE, THIS PODCAST OR THE INFORMATION PRESENTED IN THIS PODCAST. By accessing this podcast, the listener acknowledges that the entire contents and design of this podcast, are the property of SNN, or used by SNN with permission, and are protected under U.S. and international copyright and trademark laws. Except as otherwise provided herein, users of this podcast may save and use information contained in the podcast only for personal or other non-commercial educational purposes. No other use, including without limitation, reproduction, retransmission, or editing of this podcast may be made without the prior written consent of SNN.

Join Dr. Tooley and Dr. Bothun for a “from the vault” journal club we recorded back in the fall. The first article we discuss is Artificial Intelligence Chatbot Performance in Triage of Ophthalmic Conditions | medRxiv followed by JAMA publication, “Surgeon Sex and Long-Term Postoperative Outcomes Among Patients Undergoing Common Surgeries”. We hope you enjoy our discussion. Subscribe to the podcast so you don't miss future journal club episodes. https://www.medrxiv.org/content/10.1101/2023.06.11.23291247v1  https://jamanetwork.com/journals/jamasurgery/fullarticle/2808894  Subscribe to the podcast:  https://MayoClinicOphthalmology.podbean.com  Follow and reach out to us on X: @mayocliniceye 

Welcome to the Happy Nurse Educator podcast by nursing.com. Since 2018, nursing.com has been at the forefront of nursing education, guiding over 400,000 nursing students to academic success while helping the average student raise their lowest grade by 11.6% with an impressive 99.25% NCLEX pass rate. Download free Lesson Plans at HappyNurseEducator.com Must Know NCLEX Meds Lesson Plan Objective By the end of the lesson, the nursing student will be able to identify and understand key medications commonly encountered on the NCLEX, focusing on Analgesics, Anticonvulsants, Anti-inflammatory/Steroids, Anticoagulants, Anti-Parkinsonian drugs, Beta Blockers, Potassium supplements, Respiratory drugs, Cardiac Glycosides, Antihypertensives, Psychotropic drugs, Maternity drugs, Antifungals, Anticholinergics, Oncology medications, Anti-Gout medications, and Ophthalmic medications (miotics and mydriatics). Through this lesson, nursing students will acquire knowledge about medication classes, indications, contraindications, and essential nursing considerations. The emphasis will be on recognizing potential side effects, monitoring for complications, and understanding the rationale behind medication administration. This foundational knowledge will empower students to approach NCLEX questions with confidence and ensure safe medication practices in clinical  settings. Download free Lesson Plans at HappyNurseEducator.com  

Down Syndrome is the most commonly diagnosed chromosomal condition and it is one of the diagnoses we see most frequently in EAS. Listen in to hear occupational therapist and PATH Intl. CTRI, Dr. Kaiti Otte, discuss the symptoms and precautions that will apply to us in Equine Assisted Services, and highlights some teaching strategies that can help our participants with Down Syndrome be as successful as possible with their equine partners.  Other Episodes in the Series: Understanding Cerebral Palsy:  ⁠https://spotifyanchor-web.app.link/e/nVpBW0Wl0Gb⁠ Understanding ADHD: ⁠https://spotifyanchor-web.app.link/e/8xoTJXWl0Gb⁠ Follow us on social:  ⁠https://notjustaponyride.my.canva.site/linkinbio⁠ This episode is proudly sponsored by Equicizer: ⁠https://equicizer.com/ References:  CDC Statistics: de Graaf G, Buckley F, Skotko B. People living with Down syndrome in the USA: BIRTHS AND POPULATION. May 2022. https://go.dselink.net/us-population-factsheet.  Visual Impairment Stats:  Creavin, A.L., & Brown, R.D. (2009). Ophthalmic abnormalities in children with Down syndrome. Journal of Pediatrics Ophthalmology and Strabismus, 46, 46-82. Hearing Loss Stats:  Shott, S.R. (2006). Down Syndrome:  Common otolaryngologic manifestations. American Journal of Medicinal Genetics Part C (Seminars in Medical Genetics) 142C, 131-140. Accelerated Aging Stats:  Lott, I.T., & Dierssen, M. (2010). Cognitive deficits an associated neurological complications in individuals with Down Syndrome.  The Lancet Neurology, 9, 623-633. AAI Information:  Cohen, W.I., for the Down Syndrome Medical Insterest Group. (1999). Health care guidelines for individuals with Down syndrome. Down Syndrome Quarterly, 4, 1-15.

In the latest episode of the OIS Podcast, host Dr. Robert Rothman engages in a captivating dialogue with Dr. Prasad Sunkara, CEO of Eyegenex.Key points discussed in the episode:Prasad's multifaceted background spanning agricultural sciences to pharmaceuticals.Eyegenex's pioneering work in gene and peptide therapies for ophthalmic conditions.The personal journey and insights driving Prasad's commitment to advancing ophthalmology.For a deep dive into this thought-provoking conversation, tune in to the OIS Podcast and explore the forefront of ophthalmic innovation.

Blake Williamson, MD, MPH, and Gary Wörtz, MD, kick off the latest season of Ophthalmology off the Grid. This season focuses on the subject of ‘Horror Stories,' where surgeons will highlight their toughest, most complicated surgical cases and how they managed them. In this episode, Drs. Williamson and Wörtz start the discussion by sharing their own uniquely challenging cases. Learn how Dr. Williamson managed an inflammatory complication following ICL implantation, and how Dr. Wörtz approached a challenging case of suspected horror fusionis.

To learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.

We are honored to have Dr. Andrew Carey as a guest on this episode of on It Happened To Me. As a disclosure, Dr. Carey is our co-host Cathy Gildenhorn's Doctor who diagnosed her rare disease, Wolfram Syndrome.    Andrew R. Carey, MD (he/him) is an Assistant Professor of Ophthalmology in the division of Neuro-Ophthalmology at the Wilmer Eye Institute. He specializes in neuro-ophthalmic disorders such as optic neuritis, uveitis related papillitis, ischemic & hereditary optic neuropathies as well as diseases of the retina, including age-related macular degeneration, diabetic retinopathy, toxic retinopathies and inherited disorders of the retina such as retinitis pigmentosa.   Stay tuned for the next new episode of It Happened To Me! In the meantime, you can listen to our previous episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “It Happened To Me”.    It Happened To Me is created and hosted by Cathy Gildenhorn and Beth Glassman. Steve Holsonback is our media engineer and co-producer. DNA Today's Kira Dineen is our marketing lead and co-producer. Ashlyn Enokian is our graphic designer.    See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, ItHappenedToMePod.com. Questions/inquiries can be sent to ItHappenedToMePod@gmail.com.   

Thanks Dr Rahul for the insights into ophthalmic anaesthesia!check out this linkhttps://www.bjaed.org/article/S2058-5349(23)00008-2/fulltextand check out this episode on our podcast ABCs of Anaesthesia on all podcast players---------Find us atInstagram: https://www.instagram.com/abcsofanaesthesia/Twitter: https://twitter.com/abcsofaWebsite: http://www.anaesthesiacollective.comPodcast: ABCs of AnaesthesiaPrimary Exam Podcast: Anaesthesia Coffee BreakFacebook Page: https://www.facebook.com/ABCsofAnaesthesiaFacebook Private Group: https://www.facebook.com/groups/2082807131964430---------Check out all of our online courses and zoom teaching sessions here!https://anaesthesia.thinkific.com/collectionshttps://www.anaesthesiacollective.com/courses/---------#Anesthesiology #Anesthesia #Anaesthetics #Anaesthetists #Residency #MedicalSchool #FOAMed #Nurse #Medical #Meded ---------Please support me at my patreonhttps://www.patreon.com/ABCsofA---------Any questions please email abcsofanaesthesia@gmail.com---------Disclaimer: The information contained in this video/audio/graphic is for medical practitioner education only. It is not and will not be relevant for the general public.Where applicable patients have given written informed consent to the use of their images in video/photography and aware that it will be published online and visible by medical practitioners and the general public.This contains general information about medical conditions and treatments. The information is not advice and should not be treated as such. The medical information is provided “as is” without any representations or warranties, express or implied. The presenter makes no representations or warranties in relation to the medical information on this video. You must not rely on the information as an alternative to assessing and managing your patient with your treating team and consultant. You should seek your own advice from your medical practitioner in relation to any of the topics discussed in this episode' Medical information can change rapidly, and the author/s make all reasonable attempts to provide accurate information at the time of filming. There is no guarantee that the information will be accurate at the time of viewingThe information provided is within the scope of a specialist anaesthetist (FANZCA) working in Australia.The information presented here does not represent the views of any hospital or ANZCA.These videos are solely for training and education of medical practitioners, and are not an advertisement. They were not sponsored and offer no discounts, gifts or other inducements. This disclaimer was created based on a Contractology template available at http://www.contractology.com.

How can we improve the design and reporting of ophthalmic randomized controlled trials? Dr. Edmund Tsui discusses this with Dr. Gui-shuang Ying author of Ophthalmology Science's “Characteristics of Design and Analysis of Ophthalmic Randomized Controlled Trials.” Characteristics of Design and Analysis of Ophthalmic Randomized Controlled Trials. Dong, Ruiqi et al. Ophthalmology Science, Volume 3, Issue 2, 100266. Sign up for the next Ophthalmology Journal Virtual Club on October 12, 2023, at https://store.aao.org/ophthalmology-virtual-journal-club.html

Dr. Mike Chiang, Dr. Michael Boland, and Kent Mathewson join host Andrew Pouw to discuss the current state of clinical documentation in ophthalmology, the future of the electronic health record (EHR), the use of scribes, and legal considerations for documentation. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

The UK Government has announced plans to expand the number of medical specialists within the NHS. RNIB Connect Radio's Allan Russell spoke to Consultant Ophthalmic Surgeon Mr Allon Barsam, to find out more about the Medical Apprenticeships and if they are the answer to waiting times. #RNIBConnect Image shows Allon dressed in a suit with a blue tie and standing next to a window.

So my attention was piqued when I was asked recently, “We brush our teeth and moisturize our skin daily, but what do we do for our eyes?” I had to be honest and say I hadn't really thought about it... I do know that Rheumatoid Arthritis and Lupus are just two autoimmune diseases that can affect your eyesight and lead to vision loss if left unchecked... so I asked my thought-provoking questioner to sit down with us and chat about eye care and autoimmune—'that questioner' being the co-founder of MyCorneaCare.com and ophthalmic surgeon Dr. Jovi Bopari.Dr. Jovi shares simple changes that relieved him from his struggle with eye problems. And we cover a lot of eye care tips in our time together, including Dry Eye Disease and the importance of eye care even as we sleep—especially when you have an autoimmune condition. He also gives us the answers to...• When it's just' seasonal' dry eye, Dry Eye Disease, or autoimmune-driven dry eyes? • Do the blue-light-blocker glasses work, and how about sunglasses? • How body inflammation, familiar to those with autoimmune, can lead to eye dryness, sensitivity to light, blurred vision, and other eye ailments, • And the surprising sleep habits we all need to protect our eyes while we sleep and much more...More About Our Guest: Ophthalmologist and Ophthalmic Surgeon Dr. Jovi Boparai is passionate about educating patients and the world about the importance of personal eye care and Dry Eye Disease. The daily habits of increased screen time for work and personal use, seasonal allergies, contact lens use, and notable side effects of several oral medications have led to a rise in Dry Eye Disease. It's estimated that between 16 million and 49 million Americans have dry eyes. Now that's not all autoimmune related, but that 16-49 million is about 5-15% of the US population. Learn more about Dr. Boparai and CorneaCare, the company he co-founded to make eye health more accessible, at https://mycorneacare.com/Please share with family and friends: https://UnderstandingAutoimmune.com/DrJovi-2023* Your host is not a doctor or medical professional. All professionals presenting on the show only share opinions and do not give medical or other advice. Seek your own professional care and guidance if you have questions or concerns. The information presented in this interview cannot substitute for the advice of your physician or other trained medical, healthcare, or other professionals. This show is not intended to diagnose, prevent, or treat autoimmune diseases or other conditions or illnesses. The information provided on UnderstandingAutoimmune.com, Life Interrupted Radio.com, and The Autoimmune Hour is for educational purposes only. It is not a substitute for your own medical, legal, or other professional advice and care.All materials on YouTube@UnderstandingAutoimmne, The Autoimmune Hour (Show), and UnderstandingAutoimmune.com are the copyright of Competitive Edge Communications. For more videos and podcasts, visit https://www.UnderstandingAutoimmune.com.

Dr. Natalie Rosenstein author of "Ropinirole has similar efficacy to apomorphine for induction of emesis and removal of foreign and toxic gastric material in dogs in: Journal of the American Veterinary Medical Association - Ahead of print (avma.org)" discusses the use of ophthalmic solution ropinirole for the induction of emesis in dogs. Hosted by Associate Editor Dr. Sarah Wright and Editor-in-Chief Dr. Lisa Fortier.INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA OR AJVR?JAVMA: https://avma.org/JAVMAAuthorsAJVR: https://avma.org/AJVRAuthorsFOLLOW US:JAVMA:Facebook: Journal of the American Veterinary Medical Association - JAVMA | FacebookInstagram: JAVMA (@avma_javma) • Instagram photos and videosTwitter: JAVMA (@AVMAJAVMA) / Twitter AJVR: Facebook: American Journal of Veterinary Research - AJVR | FacebookInstagram: AJVR (@ajvroa) • Instagram photos and videosTwitter: AJVR (@AJVROA) / TwitterJAVMA and AJVR LinkedIn: https://linkedin.com/company/avma-journals#VeterinaryVertexPodcast #JAVMA #AJVRINTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ? JAVMA ® : https://avma.org/JAVMAAuthors AJVR ® : https://avma.org/AJVRAuthorsFOLLOW US:JAVMA ® : Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook Instagram: JAVMA (@avma_javma) • Instagram photos and videos Twitter: JAVMA (@AVMAJAVMA) / Twitter AJVR ® : Facebook: American Journal of Veterinary Research - AJVR | Facebook Instagram: AJVR (@ajvroa) • Instagram photos and videos Twitter: AJVR (@AJVROA) / Twitter JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

Ophthalmic genetic counselor Molly Marra and Dr. Lesley Everett discuss the pearls and pitfalls of genetic testing, especially in cases of suspected inherited retinal dystrophy. As discussed in the episode, the National Society of Genetic Counselors offers great tools to find genetic counselors who can advise you and your patients in the diagnostic journey. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Neuro-Otologist Nicholas Hać, MD, and Neuro-Ophthalmologist Neena Cherayil, MD, both of Northwestern Medicine, shed light on eye movement abnormalities in patients with dizziness, including their causes and significance. They discuss comprehensive evaluation and optimal management strategies for patients with dizziness and eye movement abnormalities.

What is ROSAH syndrome and how does it affect the visual function of patients with it? Dr. Tsui discusses this with Drs. Laryssa A. Huryn and Shilpa Kodati, authors of the Ophthalmology article, “Ophthalmic manifestations of ROSAH Syndrome, an inherited NF-κB mediated autoinflammatory disease with retinal dystrophy.” Ophthalmic Manifestations of ROSAH (Retinal Dystrophy, Optic Nerve Edema, Splenomegaly, Anhidrosis, and Headache) Syndrome, an Inherited NF κB–Mediated Autoinflammatory Disease with Retinal Dystrophy. Huryn, Laryssa A. et al. Ophthalmology, Volume 130, Issue 4, 423 – 432. Please tell us what you think of our show in a brief 2-minute survey: https://forms.office.com/r/B4rYtvpQad

If ophthalmology clinical trials were burgers, mitomycin would be the mustard at the table of every U.S. restaurant with a burger on the menu.*Using this analogy, Mitsol, developed and manufactured by Mobius Therapeutics, is the only FDA-approved mitomycin-c “mustard” formulation with an ophthalmic indication.In reality, the mitomycin story in ophthalmology is more complicated than that, says Ed Timm, Founder, Chairman, and CEO of Mobius Therapeutics.Mitomycin-c is used by ophthalmologists to prevent scarring during surgery. Before the FDA approved Mitosol, surgeons would have to obtain a formulation of the antimetabolite from a compounding pharmacy. Because of its instability, the effectiveness of off-label use could vary.All that changed with the arrival of Mitosol, which is a standardized product that requires no refrigeration, no light-shielding, and has a 24-month shelf life.Unfortunately, ophthalmologists still have to develop off-label formulations of other products for use during surgery, which leads to unpredictable outcomes.Mobius is doing its part to change that.With podcast host Rob Rothman, MD, Timm discusses the benefits of using an assuredly sterile, assuredly potent product and Mobius's plans to expand Mitosol's use beyond glaucoma surgery, keratectomy and pterygium.*Burger-mustard analogy courtesy of Ed TimmListen to the podcast today to discover:The Mobius strategy to expand into other indications and specialties.Timm's take on recent recalls of contaminated eye drops and what it means for development and manufacturing moving forward.Mobius's plans for growth over the next few years, including potential strategic partnerships.Timm's professional background, which took him from American Hospital Supply to building Synergetics (later sold to Bausch + Lomb) to Mobius Therapeutics.What Dr. Rothman sees as a recurring theme in ophthalmology and how it creates better leaders and investors.[Press Play]

Welcome to another episode of The Action and Ambition Podcast! Joining us today is Dr. Juanita Collier, a Behavioral Optometrist who has been published in Ophthalmic and Physical Optics, the Journal of the College of Optometrists, Optometry, Journal of the American Optometric Association and Review of Optometry who specializes in post-concussion care, vision-related learning difficulties, and primary vision care for patients of all ages. She is the Founder of 4D Vision Gym, which helps children and adults experiencing visual challenges. Don't miss a thing on this. Tune in to learn more!

Conjunctivitis, commonly known as pink eye, is a common eye infection that presents at pediatrician offices and often keeps kids out of school or daycare. Although conjunctivitis is commonly caused by viral infections, there are other reasons why a patient might get pink eye. As a pediatric provider, it is essential to understand the signs and symptoms of pink eye and to weigh the risks and benefits of prescribing antibiotics. This episode discusses the treatment of conjunctivitis and the role pediatricians play in antibiotic stewardship.   Guest: Nicole Poole, MD, is an assistant professor of pediatrics in the Division of Infectious Diseases at the University of Colorado and the Associate Medical Director of the Antibiotic Stewardship Program at Children's Hospital Colorado.   Episode resources:  Colorado Department of Public Health and Environment (CDPHE) website: https://cdphe.colorado.gov/child-care-health-regulations How Sick is Too Sick? (CDPHE): https://drive.google.com/file/d/1RcdCmU4SYXwmVhJrA3Pyk0gP0MTDClkF/view  AAP Managing Infectious Diseases in Child Care and Schools: https://shop.aap.org/managing-infectious-diseases-in-child-care-and-schools-6th-edition-paperback/ Ophthalmic antibiotic use for acute infectious conjunctivitis in children: https://pubmed.ncbi.nlm.nih.gov/34737083/ Uncomplicated Acute Respiratory Tract Infections (ARTI) Clinical Pathways: https://www.childrenscolorado.org/health-professionals/clinical-resources/clinical-pathways/uncomplicated-acute-respiratory-tract-infections/     For more information on Children's Hospital Colorado, visit: childrenscolorado.org   

Obada Subei with The Brain and Eye Institute Danielle Remington with Ophthalmic Surgeons and Physicians and Patient Carly Norton The Brain and Eye Institute is Arizona’s only Neuro-Ophthalmic service provider accepting new patients. It is directed by Dr. Obada Subei. The Brain and Eye Institute's mission is to provide the entire state of Arizona with […] The post Obada Subei with The Brain and Eye Institute Danielle Remington with Ophthalmic Surgeons and Physicians and Patient Carly Norton appeared first on Business RadioX ®.

Nearly all of us will come in contact with some type of Ophthalmic surgical instruments at some point in our careers. But a few of us may end up on the patient side of those instruments as well. On our final episode of Season 19, "The Surgeons We Serve," Lindsay Brown joins us as a cohost for a special interview as we speak with Jill Melicher, MD, Ophthalmic Plastic, Orbit and Reconstructive Surgeon at Minnesota Eye Consultants to discuss the life-saving procedure Dr. Melicher performed on Lindsay in the summer of 2022.  Tune in as we talk about the journey Dr. Melicher took to become an Ophthalmic surgeon, the nuances of surgical instruments used in eye procedures, and Lindsay's personal surgical experience to where Dr. Melicher removed cancer from one of her eyes. How do surgeons approach procedures like this? What part do Sterile Processing technicians play in these life-saving moments? Join us this week to find out!   This episode is currently pending CE approval. Once you finish this interview, check back in a few days at the link below for access to the CE quiz for this episode, along with over 300 other free CE credits on our CE Credit Hub: http://www.beyondclean.net/ce-credit-hub   Thanks again for supporting this amazing season spotlighting the intersection of surgeons, surgical instruments, and the #CleanFreaks that help make it all happen!

CMSgt Polanco was amazing. She was in Security Forces, then retrained into the Ophthalmic AFSC. Today she's talking to us about what exactly an Ophthalmic Tech does and what their career might look like. Spoiler alert, she thinks it's a great career field! Be sure to show your support by checking out her YouTube pages and website.-Mary Polanco Designs: https://www.youtube.com/@marypolancodesigns-Live Well with Mary Polanco: https://www.youtube.com/@livewellmarypolanco-Mary Polanco Website: http://marypolanco.com/ 4V0X1 AFSC Page: https://foreverwingman.com/career_fields/4v0x1-ophthalmic/Want to help the next generation Airmen by sharing your Air Force story? I'd love to have you on the show: https://foreverwingman.com/interview/ Looking to learn more about the Air Force? The most comprehensive information on all of the Air Force jobs: https://foreverwingman.com/air-force-jobs/ Search and Filter AFSCs: https://foreverwingman.com/search-afsc/ Study for Air Force Basic Training: https://foreverwingman.com/afbmt-course/ Forever Wingman Podcast (leave a review!): https://foreverwingman.buzzsprout.com/ Facebook Group: https://www.facebook.com/groups/foreverwingman

Dr. Amanda Redfern speaks with Drs. Maggie Hymowitz and Donna Kim about the role of the ophthalmic hospitalist, a burgeoning profession in ophthalmology with increased demand. The discussion ranges from how to get started in the field, benefits and challenges of the role, and future directions. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

2023 MIDWEST VETERINARY CONFERENCE PREVIEW SERIES For many general practitioners, ophthalmology is intimidating. Even if you can translate the language of eyes into regular English (just what is a uvea, anyway?), offering eye exams and accurately diagnosing your patients' leaky, red eyes or sudden blindness requires expensive specialized equipment and advanced training that you don't have. Referring clients to a specialist is the only option. Or is it? In this episode, veterinary ophthalmologist Dr. Kate Myrna shares some good news: Ophthalmology doesn't always have to be complicated! There are ways to simplify eye exams and make accurate diagnoses using simple tools you already have on hand. If you're intrigued by what you hear, be sure to sign up for her sessions at the 2023 MVC. =-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-= For show notes, a transcript, and to learn more about today's guests, please visit www.fullyvettedpodcast.com. =-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-= ✱ Never miss an episode! Subscribe to email alerts » --- Send in a voice message: https://anchor.fm/fully-vetted/message

In the third episode of Be the Change, we speak with Dr Rengaraj Venkatesh (Chief Medical Officer at Aravind Eye Hospital, Pondicherry), about what makes Aravind a global leader in delivering Sustainable eye care, and the steps that Ophthalmic care units around the world need to be taking in order to tackle the climate crisis.

On this Episode of the ASC Podcast with John Goehle, we discuss the latest news including ASORNs Recommended Practice regarding the use of Multi-dose Ophthalmic Medications,  Key Findings in a recent Avanza Study on Hospital ASC Investment, New about CMS increasing Dental Surgery Reimbursement for Hospital Outpatient Surgery Departments and in our focus segment, discuss interoperability in the ambulatory surgery center with Lindsay Hanrahan,  SIS - Vice President of Product Management. .   This episode is sponsored by Surgical Information Systems   Resources from this Episode: SIS - Surgical Information Systems (The Sponsor) ASORN Recommended Practice: Use of Multi-dose Medicationshttps://asorn.org/assets/Use-of-Multi-dose-Medications.pdf Avanza Healthcare Strategies - Avanza Intelligence 2021-22 Hospital Leaders ASC Survey:https://avanzastrategies.com/intelligence-report/avanza-intelligence-2021-2022-hospital-leadership-asc-survey/ CMS issues proposed rule that would improve access to dental surgeries in hospitals - American Dental Associationhttps://www.ada.org/publications/ada-news/2022/july/cms-issues-proposed-rule-that-would-improve-access-to-dental-surgeries-in-hospitals Important Resources for ASCs: Conditions for Coverage: https://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&rgn=div5&view=text&node=42:3.0.1.1.3&idno=42#se42.3.416_150 Updated Guidance for Ambulatory Surgical Centers - Appendix L of the State Operations Manual (SOM)https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107ap_l_ambulatory.pdf https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/updated-guidance-ambulatory-surgical-centers-appendix-l-state-operations-manual-som Policy & Memos to States and RegionsCMS Quality Safety & Oversight memoranda, guidance, clarifications and instructions to State Survey Agencies and CMS Regional Offices. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions Other Resources from the ASC Podcast with John Goehle: Upcoming Conferences: ASC Finance, Accounting & Reimbursement Seminar: Get a copy of John's most popular book - The Survey Guide - A Guide to the CMS Conditions for Coverage & Interpretive Guidelines for Ambulatory Surgery Centers  Visit the ASC Podcast with John Goehle Website Benefits of Becoming a Patron Member Patron Members of the ASC Podcast with John Goehle have access to ASC Central - an exclusive membership website that provides a one-stop  ASC Regulatory and Accreditation Compliance, Operations and Financial Management resource for busy Administrators, nurse managers and business office managers.   Become a member today!

Welcome back to Season 2, Episode 153 of the Asian Hustle Network Podcast! We are very excited to have Dr. Dagny Zhu on this week's show. Honor AANHPI heritage, communities, and families today by getting vaccinated for a safer tomorrow. Vaccination greatly reduces your chance of having COVID symptoms like fatigue, pain, and memory problems that last for months. Protect your tomorrow with a vaccine today. Talk to a doctor if you have questions. Find vaccines and boosters near you at vaccines.gov. We can do this. Paid for by the U.S. Department of Health and Human Services. Dr. Zhu is a Harvard-educated, board-certified ophthalmologist who specializes in cornea, cataract, and refractive surgery. She is the owner and Medical Director of Hyperspeed LASIK (an NVISION Eye Centers company) in Rowland Heights, California As a key opinion leader in advanced laser vision correction and premium cataract surgery, Dr. Zhu serves as a medical advisor to multiple ophthalmic companies and has been featured in over 200 lectures, presentations, publications, and press features, including The Today Show, Huffington Post, InStyle, Yahoo News, NBC News, and CNN. Notably, Dr. Zhu has garnered a large social media presence as a podcast co-host and healthcare influencer (50k+ followers on Instagram @DZEyeMD), where she promotes health and science, champions for women and people of color, and provides inspiration and mentorship to the next generation. To stay connected within the AHN community, please join our AHN directory: bit.ly/AHNDirectory Episode segments --- Support this podcast: https://anchor.fm/asianhustlenetwork/support